CHAPTER ONE
INTRODUCTION
1.1 Background to the Study
Breast
cancer is the most common malignancy and first cause of cancer mortality in women
worldwide with a world number of new cases estimated at 1,384,155 in 2008.[1]
Its worldwide prevalence is still on the rise[2, 3] and nowadays breast cancer
is considered to be an increasing public health problem among populations in
low- and middle-income countries (LMICs). Moreover, a recent population-based
study of cancer survival in Africa, Asia and Central America found unacceptably
low breast cancer survival rates in African countries especially in Gambia
where the 5-year age-standardized relative survival did not exceed 12%.[4]
Globally,
breast cancer has been identified as a leading cause of death globally (1,2).
There are more than a million new cases of breast cancer resulting in about
875,000 deaths each year, with high mortality rates in developing countries
(3). In Nigeria, breast cancer has been reported to account for 56.6% of all
cancer diagnosis between 1995&2002 (4). The burden of the disease has been
on the increase and affected women often present late in hospitals when it has
reached advance stage (5). Its cure at this stage becomes seriously
compromised; the poor survival rate has been linked to late detection and
diagnosis(6). Cancer is a disease process that begins when an abnormal cells is
transformed by the genetic mutation of the cellular Deoxyribonuleic acids
(DNA)(7). Breast cancer is neither painful nor cause any discomfort in its
early stage. It usually present as a painless breast lump. There are diverse
risk factors that may affect each woman's susceptibility to the disease(3).
Besides
poverty, low public awareness of breast cancer is a barrier to breast cancer
control in LMICs where women seek medical help late and cancers are often
diagnosed at advanced stages when very little can be done in terms of curative
treatment. The Breast Health Global Initiative (BHGI) panel[5, 6] has
recommended implementation strategies to optimize breast cancer management in
LMICs concerning health-care systems, breast cancer diagnosis, treatment and
early detection. For early detection, efforts must be devoted to improve
community awareness. Civil society, represented by non-governmental
organizations (NGOs), can play an important role in breast cancer control.[7]
In
Ghana, 2,062 new breast cancer cases and 1,137 breast cancer deaths were estimated
annually (16.5% of all women cancer deaths), with age-standardized incidence
and mortality rates of 25.8 and 15.2 per 100,000 women, respectively (Globocan
2008).[1] Sixty percent of cases were detected at late stages (IIB, III and
IV).[8] The available data on median age are limited and mainly hospital based.
Clegg-Lamptey et al. reported a median age at diagnosis of 43 years on a sample
of 66 women newly diagnosed with breast cancer. The age range was broad, from
20 to 84 years.[8] Surgery still represents the main form of treatment for
breast cancer in the country[9] and as in other African countries some cultural
beliefs and mysticisms surround the disease.[10]
1.2
Problem Statement
To
date, little research has been done regarding the impact of awareness programs
in breast cancer control in Nigeria and even less at the community level in
rural areas. hence there is need to assess the impact of breast cancer
awareness programmes on the prevention of breast cancer amongst Nigerian women.
1.3
Objectives of the study
The
major objective of the study is the impact of breast cancer awareness
programmes on the prevention of breast cancer amongst Nigerian women.
1.4
Research questions
(1)
what is breast cancer
(2)
How can it be prevented?
(3)
what effect does breast cancer awareness programmes have on the prevalence of
breast cancer?
1.5
Significance of the study.
Our
study aimed to assess the impact of breast cancer awareness programmes on the
prevention of breast cancer amongst Nigerian women.
1.6
Scope of the study
The
research focus on the impact of breast cancer awareness programmes on the
prevention of breast cancer amongst Nigerian women.
References
1.
Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, cancer incidence and mortality
worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International
Agency for Research on Cancer, 2010. Available at: http://globocan.iarc.fr
(Accessed June 21, 2013).
2.
Sasco AJ. Cancer and globalization. Biomed Pharmacother 2008;62:110–21.
CrossRef
| PubMed | CAS | Web of Science® Times Cited: 16
3.
Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer
in 187 countries between 1980 and 2010: a systematic analysis. Lancet
2011;378:1461–84.
CrossRef
| PubMed | Web of Science® Times Cited: 348
4.
Sankaranarayanan R Swaminathan R, Brenner H, et al. Cancer survival in Africa,
Asia, and Central America: a population-based study. Lancet Oncol
2010;11:165–73.
CrossRef
| PubMed | Web of Science® Times Cited: 139
5.
Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer
management in low-resource and middle-resource countries: executive summary of
the Breast Health Global Initiative consensus, 2010. Lancet Oncol
2011;12:387–98.
CrossRef
| PubMed | Web of Science® Times Cited: 89
6.
El Saghir NS, Adebamowo CA, Anderson BO, et al. Breast cancer management in low
resource countries (LRCs): consensus statement from the Breast Health Global
Initiative. Breast 2011;20:S3–S11.
CrossRef
| PubMed | Web of Science® Times Cited: 42
7.
Azenha G, Bass LP, Caleffi M, et al. The role of breast cancer civil society in
different resource settings. Breast 2011;20(Suppl 2):S81–S87.
CrossRef
| PubMed | Web of Science® Times Cited: 5
8.
Clegg-Lamptey J, Dakubo J, Attobra YN. Why do breast cancer patients report
late or abscond during treatment in Ghana? A pilot study. Ghana Med J
2009;43:127–31.
PubMed
9.
Clegg-Lamptey J, Hodasi WM. A study of breast cancer in Korle-Bu teaching
hospital: assessing the impact of health education. Ghana Med J 2007;41:73–7.
10.Okobia
MN, Bunker CH, Okonofua FH, et al. Knowledge, attitude and practice of Nigerian
women towards breast cancer: a cross-sectional study. World J Surg Oncol
2006;4:11.
CrossRef
| PubMed